香港股市 已收市

BioNTech SE (BNTX)

NasdaqGS - NasdaqGS 即時價格。貨幣為 USD。
加入追蹤清單
92.08-3.92 (-4.08%)
收市:04:00PM EDT
92.25 +0.17 (+0.18%)
收市後: 07:40PM EDT
全螢幕
交易股價資料並非來自所有市場
前收市價96.00
開市94.56
買盤92.02 x 100
賣出價92.16 x 100
今日波幅92.01 - 95.24
52 週波幅85.21 - 125.83
成交量750,541
平均成交量735,393
市值22.19B
Beta 值 (5 年,每月)0.27
市盈率 (最近 12 個月)180.55
每股盈利 (最近 12 個月)0.51
業績公佈日2024年8月05日
遠期股息及收益率無 (無)
除息日2022年6月02日
1 年預測目標價113.52
  • Motley Fool

    Why Vaccine Stocks Rallied This Week

    A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?

  • Benzinga

    European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech

    Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing legal battle with Pfizer Inc (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) over the Covid-19 vaccine. The EPO’s Opposition Division upheld the validity of one of Moderna’s crucial patents, boosting the mRNA vaccine maker’s efforts to reclaim pandemic profits from its competitors, the Financial Times reports. Although Pfizer has nine months to appeal the decision, the EPO’s writte

  • Insider Monkey

    BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript

    BioNTech SE (NASDAQ:BNTX) Q1 2024 Earnings Call Transcript May 6, 2024 BioNTech SE isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to BioNTech’s First Quarter 2024 Earnings Call. I would like to hand the call over to Dr. Victoria […]